SSAO inhibitor-3 (Compound 2) can be used in the study of atherosclerosis, diabetes and its complications, obesity, stroke, chronic kidney disease, retinopathy, chronic obstructive pulmonary disease (COPD), autoimmune diseases, multiple sclerosis, etc. SSAO inhibitor-3 is an inhibitor of semicarbazide-sensitive amine oxidase (SSAO) with IC 50 s of 0.1-10 μM and <10 nM for human AOC1 and SSAO, respectively [1].